{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:25:07Z","timestamp":1794540307562,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mahkota Dewa [<jats:italic>Phaleria macrocarpa<\/jats:italic> (Scheff) Boerl.] fruit in vitro and <jats:italic>in- vivo<\/jats:italic> can decrease and prevent elevation of the blood pressure, lower plasma glucose levels, possess an antioxidant effect, and recover liver and kidney damage in rats. This study aimed to determine the structure and inhibitory activity of angiotensin-converting enzyme inhibitors (ACE) from the Mahkota Dewa fruit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The fruit powder was macerated using methanol and then partitioned by hexane, ethyl acetate, n-butanol, and water. The fractions were chromatographed on the column chromatography and incorporated with TLC and recrystallization to give pure compounds. The structures of isolated compounds were determined by UV-Visible, FT-IR, MS, proton (<jats:sup>1<\/jats:sup>H-NMR), carbon (<jats:sup>13<\/jats:sup>C-NMR), and 2D-NMR techniques encompassing HMQC and HMBC spectra. The compounds were evaluated for their ACE inhibitory activity, and the strongest compound was determined by the kinetics enzyme inhibition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Based on the spectral data, the isolated compounds were determined as 6,4-dihydroxy-4-methoxybenzophenone\u20132-O-\u03b2-D-glucopyranoside (1), 4,4\u2032-dihydroxy-6-methoxybenzophenone-2-O-\u03b2-D-glucopyranoside (2) and mangiferin (3). IC<jats:sub>50<\/jats:sub> values of the isolated compounds 1, 2 and 3 were 0.055, 0.07, and 0.025\u2009mM, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The three compounds have ACE inhibitor and mangiferin demonstrated the best ACE inhibitory activity with competitive inhibition on ACE with the type of inhibition kinetics is competitive inhibition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-03889-x","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:03:47Z","timestamp":1676883827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Angiotensin converting enzyme (ACE) inhibitors activity from purified compounds Fructus Phaleria macrocarpa (Scheff) Boerl"],"prefix":"10.1186","volume":"23","author":[{"given":"Aprilita Rina Yanti","family":"Eff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasniza Zaman","family":"Huri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksum","family":"Radji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Mun\u2019im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. D.","family":"Suyatna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan","family":"Eden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"issue":"17","key":"3889_CR1","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1001\/jama.2018.16760","volume":"320","author":"ND Fisher","year":"2018","unstructured":"Fisher ND, Curfman G. Hypertension\u2014A public health challenge of global proportions. JAMA - J Am Med Assoc. 2018;320(17):1757\u20139. https:\/\/doi.org\/10.1001\/jama.2018.16760.","journal-title":"JAMA - J Am Med Assoc"},{"issue":"8","key":"3889_CR2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/heapol\/czw022","volume":"31","author":"O Oyebode","year":"2016","unstructured":"Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: A WHO-SAGE study. Health Policy Plan. 2016;31(8):984\u201391. https:\/\/doi.org\/10.1093\/heapol\/czw022.","journal-title":"Health Policy Plan"},{"issue":"5","key":"3889_CR3","first-page":"49","volume":"4","author":"A Batool","year":"2018","unstructured":"Batool A, Sultana M, Gilani P, Javed T. Risk factors, pathophysiology and management of hypertension. Int J Pharma Sci Sci Res. 2018;4(5):49\u201361.","journal-title":"Int J Pharma Sci Sci Res"},{"issue":"11","key":"3889_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4070\/kcj.2019.0261","volume":"49","author":"S Park","year":"2019","unstructured":"Park S. Ideal target blood pressure in hypertension. Korean Circ J. 2019;49(11):1002\u20139. https:\/\/doi.org\/10.4070\/kcj.2019.0261.","journal-title":"Korean Circ J"},{"issue":"4","key":"3889_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1124\/pr.118.017129","volume":"71","author":"LB Arendse","year":"2019","unstructured":"Arendse LB, Jan Danser AH, Poglitsch M, Touyz RM, Burnett JC, Llorens-Cortes C, et al. Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev. 2019;71(4):539\u201370. https:\/\/doi.org\/10.1124\/pr.118.017129.","journal-title":"Pharmacol Rev"},{"issue":"5","key":"3889_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2215\/CJN.04330418","volume":"14","author":"AD Sinha","year":"2019","unstructured":"Sinha AD, Agarwal R. Clinical pharmacology of antihypertensive therapy for the treatment of hypertension in CKD. Clin J Am Soc Nephrol. 2019;14(5):757\u201364. https:\/\/doi.org\/10.2215\/CJN.04330418.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"3889_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/0973-7847.79097","volume":"5","author":"N Tabassum","year":"2011","unstructured":"Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011;5(9):30\u201340. https:\/\/doi.org\/10.4103\/0973-7847.79097.","journal-title":"Pharmacogn Rev"},{"issue":"77","key":"3889_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-017-0775-5","volume":"19","author":"SG Chrysant","year":"2017","unstructured":"Chrysant SG, Chrysant GS. Herbs used for the treatment of hypertension and their mechanism of action. Curr Hypertens Rep. 2017;19(77):1\u201310. https:\/\/doi.org\/10.1007\/s11906-017-0775-5.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"3889_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.20473\/jovin.v1i1.19915","volume":"1","author":"MF Rizal","year":"2020","unstructured":"Rizal MF, Haryanto J, Has EMM. The effect of Phaleria Macrocarpa ethnic food complementary to decrease blood pressure. J Vocat Nurs. 2020;1(1):73. https:\/\/doi.org\/10.20473\/jovin.v1i1.19915.","journal-title":"J Vocat Nurs"},{"issue":"1","key":"3889_CR10","first-page":"527","volume":"4","author":"A Rinayanti","year":"2013","unstructured":"Rinayanti A, Radji M, Mun A, Suyatna FD. Screening angiotensin converting enzyme (ACE) inhibitor activity of antihypertensive medicinal plants from Indonesia. Int J Pharm Teach Pract. 2013;4(1):527\u201332.","journal-title":"Int J Pharm Teach Pract"},{"key":"3889_CR11","doi-asserted-by":"publisher","unstructured":"Alara OR, Alara J, Olelare OA. Review on Phaleria macrocarpa pharmacological and phytochemical properties. Drug Des Open Access. 2016;05(03). https:\/\/doi.org\/10.4172\/2169-0138.1000134.","DOI":"10.4172\/2169-0138.1000134"},{"issue":"2","key":"3889_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11418-007-0209-9","volume":"62","author":"S Oshimi","year":"2008","unstructured":"Oshimi S, Zaima K, Matsuno Y, Hirasawa Y, Iizuka T, Studiawan H, et al. Studies on the constituents from the fruits of Phaleria macrocarpa. J Nat Med. 2008;62(2):207\u201310. https:\/\/doi.org\/10.1007\/s11418-007-0209-9.","journal-title":"J Nat Med"},{"key":"3889_CR13","doi-asserted-by":"publisher","unstructured":"Lay MM, Karsani SA, Banisalam B, Mohajer S, Abd Malek SN. Antioxidants, phytochemicals, and cytotoxicity studies on Phaleria macrocarpa (Scheff.) Boerl seeds. Biomed Res Int. 2014;2014. https:\/\/doi.org\/10.1155\/2014\/410184.","DOI":"10.1155\/2014\/410184"},{"issue":"9","key":"3889_CR14","first-page":"41","volume":"8","author":"AR Yanti","year":"2015","unstructured":"Yanti AR, Radji M, Mun\u2019Im A, Suyatna FD. Antioxidant effects of methanolic extract of Phaleria macrocarpa (Scheff.) boerl in fructose 10%-induced rats. Int J PharmTech Res. 2015;8(9):41\u20137.","journal-title":"Int J PharmTech Res"},{"issue":"4","key":"3889_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.apjtb.2016.12.018","volume":"7","author":"ED Ramdani","year":"2017","unstructured":"Ramdani ED, Marlupi UD, Sinambela J, Tjandrawinata RR. Isolation and identification of compounds from Phaleria macrocarpa (Scheff.) Boerl fruit extract. Asian Pac J Trop Biomed. 2017;7(4):300\u20135. https:\/\/doi.org\/10.1016\/j.apjtb.2016.12.018.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"1","key":"3889_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-018-0177-x","volume":"13","author":"QW Zhang","year":"2018","unstructured":"Zhang QW, Lin LG, Ye WC. Techniques for extraction and isolation of natural products: a comprehensive review. Chin Med (United Kingdom). 2018;13(1):1\u201326. https:\/\/doi.org\/10.1186\/s13020-018-0177-x.","journal-title":"Chin Med (United Kingdom)"},{"issue":"3","key":"3889_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.5530\/pj.2020.12.65","volume":"12","author":"ARY Eff","year":"2020","unstructured":"Eff ARY, Rahayu ST, Mahayasih PG, Januarko MU. Standardization of Indonesian traditional antihypertensive medicines (JAMU) through the ACE inhibitor mechanism. Pharmacogn J. 2020;12(3):422\u20139. https:\/\/doi.org\/10.5530\/pj.2020.12.65.","journal-title":"Pharmacogn J"},{"issue":"2","key":"3889_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1039\/C8RP00276B","volume":"20","author":"JMG Rodriguez","year":"2019","unstructured":"Rodriguez JMG, Towns MH. Analysis of student reasoning about Michaelis-Menten enzyme kinetics: mixed conceptions of enzyme inhibition. Chem Educ Res Pract. 2019;20(2):428\u201342. https:\/\/doi.org\/10.1039\/C8RP00276B.","journal-title":"Chem Educ Res Pract"},{"key":"3889_CR19","first-page":"1","volume-title":"StatPearls","author":"F JH","year":"2021","unstructured":"JH F, Sl L. Physiology, Renin angiotensin system organ systems involved continuing education \/ review questions publication details author information. In:  StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. p. 1\u20139."},{"issue":"1","key":"3889_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.22146\/ijc.21576","volume":"9","author":"H Winarno","year":"2009","unstructured":"Winarno H, Katrin WE. Benzophenone glucoside isolated from the ethyl acetate extract of the bark of Mahkota dewa [Phaleria macrocarpa (Scheff.) Boerl.] and its inhibitory activity on leukemia L1210 cell line. Indones J Chem. 2009;9(1):142\u20135. https:\/\/doi.org\/10.22146\/ijc.21576.","journal-title":"Indones J Chem"},{"issue":"1\u20132","key":"3889_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/10286020500480472","volume":"8","author":"YB Zhang","year":"2006","unstructured":"Zhang YB, Xu XJ, Liu HM. Chemical constituents from Mahkota dewa. J Asian Nat Prod Res. 2006;8(1\u20132):119\u201323. https:\/\/doi.org\/10.1080\/10286020500480472.","journal-title":"J Asian Nat Prod Res"},{"issue":"22","key":"3889_CR22","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1016\/j.bmcl.2012.09.038","volume":"22","author":"SY Zhang","year":"2012","unstructured":"Zhang SY, Zhang QH, Zhao W, Zhang X, Zhang Q, Bi YF, et al. Isolation, characterization and cytotoxic activity of benzophenone glucopyranosides from Mahkota Dewa (Phaleria macrocarpa (Scheff.) Boerl). Bioorganic Med Chem Lett. 2012;22(22):6862\u20136. https:\/\/doi.org\/10.1016\/j.bmcl.2012.09.038.","journal-title":"Bioorganic Med Chem Lett"},{"issue":"4","key":"3889_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/0974-8490.69110","volume":"2","author":"PC Djemgou","year":"2010","unstructured":"Djemgou PC, Hussien TA, Hegazy MEF, Ngandeu F, Neguim G, Tane P, et al. C-glucoside xanthone from the stem bark extract of Bersama engleriana. Pharm Res. 2010;2(4):229\u201332. https:\/\/doi.org\/10.4103\/0974-8490.69110.","journal-title":"Pharm Res"},{"issue":"6","key":"3889_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.joim.2021.09.006","volume":"19","author":"R Chakraborty","year":"2021","unstructured":"Chakraborty R, Roy S. Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. J Integr Med. 2021;19(6):478\u201392. https:\/\/doi.org\/10.1016\/j.joim.2021.09.006.","journal-title":"J Integr Med"},{"issue":"2","key":"3889_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/phrev.phrev_45_16","volume":"1","author":"I Ahmad","year":"2018","unstructured":"Ahmad I, Yanuar A, Mulia K, Mun\u2019im A. Review of angiotensin-converting enzyme inhibitory assay: rapid method in drug discovery of herbal plants. Pharmacogn Rev. 2018;1(2):1\u20137. https:\/\/doi.org\/10.4103\/phrev.phrev_45_16.","journal-title":"Pharmacogn Rev"},{"issue":"7","key":"3889_CR26","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/0006-2952(71)90292-9","volume":"20","author":"DW Cushman","year":"1971","unstructured":"Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20(7):1637\u201348. https:\/\/doi.org\/10.1016\/0006-2952(71)90292-9.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3889_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/bmb.21235","volume":"47","author":"TP Silverstein","year":"2019","unstructured":"Silverstein TP. When both km and Vmax are altered, is the enzyme inhibited or activated? Biochem Mol Biol Educ. 2019;47(4):446\u20139. https:\/\/doi.org\/10.1002\/bmb.21235.","journal-title":"Biochem Mol Biol Educ"},{"issue":"6","key":"3889_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7897\/2230-8407.1206145","volume":"12","author":"N Patadiya","year":"2021","unstructured":"Patadiya N, Panchal N, Vaghela V. A review on enzyme inhibitors. Int Res J Pharm. 2021;12(6):60\u20136. https:\/\/doi.org\/10.7897\/2230-8407.1206145.","journal-title":"Int Res J Pharm"},{"issue":"2","key":"3889_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.15406\/atroa.2019.05.00104","volume":"5","author":"A Ouertani","year":"2019","unstructured":"Ouertani A, Neifar M, Ouertani R, Masmoudi AS, Cherif A. Effectiveness of enzyme inhibitors in biomedicine and pharmacotherapy. Adv Tissue Eng Regen Med Open Access. 2019;5(2):85\u201390. https:\/\/doi.org\/10.15406\/atroa.2019.05.00104.","journal-title":"Adv Tissue Eng Regen Med Open Access"},{"issue":"4","key":"3889_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0215609","volume":"14","author":"L Fang","year":"2019","unstructured":"Fang L, Geng M, Liu C, Wang J, Min W, Liu J. Structural and molecular basis of angiotensin-converting enzyme by computational modeling: insights into the mechanisms of different inhibitors. PLoS One. 2019;14(4):1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0215609.","journal-title":"PLoS One"},{"issue":"1","key":"3889_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jep.2009.09.059","volume":"127","author":"D Ojeda","year":"2010","unstructured":"Ojeda D, Jim\u00e9nez-Ferrer E, Zamilpa A, Herrera-Arellano A, Tortoriello J, Alvarez L. Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol. 2010;127(1):7\u201310. https:\/\/doi.org\/10.1016\/j.jep.2009.09.059.","journal-title":"J Ethnopharmacol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-03889-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-03889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:03:53Z","timestamp":1676883833000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-03889-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3889"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-03889-x","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}